ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS

Clinical trials for ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS explained in plain language.

Never miss a new study

Get alerted when new ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS trials appear

Sign up with your email to follow new studies for ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Experimental drug delivery for rare lung bleeding condition under study

Disease control Recruiting now

This early-phase study looks at how the body processes a liquid form of the drug avacopan when given through a feeding tube. It involves up to 6 patients with a rare autoimmune disease (ANCA vasculitis) who have severe lung bleeding and need a breathing machine. The goal is to me…

Matched conditions: ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS

Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated May 26, 2026 08:10 UTC

ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS

Get alerted when new ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS trials appear

Experimental drug delivery for rare lung bleeding condition under study